These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21191770)

  • 1. Crystal forms of SK-3530.
    Song HO; Sohn YT
    Arch Pharm Res; 2010 Dec; 33(12):2033-6. PubMed ID: 21191770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal forms of naproxen.
    Song JS; Sohn YT
    Arch Pharm Res; 2011 Jan; 34(1):87-90. PubMed ID: 21468919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal forms of atorvastatin.
    An SG; Sohn YT
    Arch Pharm Res; 2009 Jun; 32(6):933-6. PubMed ID: 19557372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid state of CG-400549, a novel FabI inhibitor: characterization, dissolution, transformation.
    Kim BY; Sohn YT
    Arch Pharm Res; 2011 May; 34(5):775-9. PubMed ID: 21656363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid state of a new PDE-5 inhibitor DA-8159: characterization, dissolution, transformation.
    Ryu JY; Sohn YT
    Arch Pharm Res; 2012 May; 35(5):861-6. PubMed ID: 22644853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal form of cephradine.
    Sohn YT; Park SH
    Arch Pharm Res; 2006 Feb; 29(2):178-82. PubMed ID: 16526284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism and pseudopolymorphism of acyclovir.
    Sohn YT; Kim SH
    Arch Pharm Res; 2008 Feb; 31(2):231-4. PubMed ID: 18365695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-state properties and crystallization behavior of PHA-739521 polymorphs.
    Sun CC
    Int J Pharm; 2006 Aug; 319(1-2):114-20. PubMed ID: 16720086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal modification of dipyridamole using different solvents and crystallization conditions.
    Adhiyaman R; Basu SK
    Int J Pharm; 2006 Sep; 321(1-2):27-34. PubMed ID: 16842943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the physicochemical properties of KRK-701P.
    Bang IJ; Kim BJ; Sohn YT
    Arch Pharm Res; 2015; 38(5):834-8. PubMed ID: 25052957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of polymorphic forms of ranitidine hydrochloride.
    Wu V; Rades T; Saville DJ
    Pharmazie; 2000 Jul; 55(7):508-12. PubMed ID: 10944778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery of UK-369003, a novel PDE5 inhibitor with the potential for oral bioavailability and dose-proportional pharmacokinetics.
    Rawson DJ; Ballard S; Barber C; Barker L; Beaumont K; Bunnage M; Cole S; Corless M; Denton S; Ellis D; Floc'h M; Foster L; Gosset J; Holmwood F; Lane C; Leahy D; Mathias J; Maw G; Million W; Poinsard C; Price J; Russel R; Street S; Watson L
    Bioorg Med Chem; 2012 Jan; 20(1):498-509. PubMed ID: 22100260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of amorphization methods on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K; Sawicki W; Paluch KJ; Tajber L; Grembecka M; Hawelek L; Wojnarowska Z; Grzybowska K; Talik E; Paluch M
    Eur J Pharm Sci; 2014 Oct; 62():132-40. PubMed ID: 24907679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of two polymorphs of lornoxicam.
    Zhang J; Tan X; Gao J; Fan W; Gao Y; Qian S
    J Pharm Pharmacol; 2013 Jan; 65(1):44-52. PubMed ID: 23215687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The solid-state characterization of fusidic acid.
    Gilchrist SE; Letchford K; Burt HM
    Int J Pharm; 2012 Jan; 422(1-2):245-53. PubMed ID: 22100514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.
    Park HJ; Kim MS; Lee S; Kim JS; Woo JS; Park JS; Hwang SJ
    Int J Pharm; 2007 Jan; 328(2):152-60. PubMed ID: 16959448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal forms of the hydrogen oxalate salt of o-desmethylvenlafaxine.
    Dichiarante E; Curzi M; Giaffreda SL; Grepioni F; Maini L; Braga D
    J Pharm Pharmacol; 2015 Jun; 67(6):823-9. PubMed ID: 25644936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The solid state of rebamipide: preparation, characterization, and dissolution.
    Jeon SH; Sohn YT
    Arch Pharm Res; 2016 Apr; 39(4):508-515. PubMed ID: 26897596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of process induced polymorphic transformations in fluconazole drug.
    Desai SR; Dharwadkar SR
    Acta Pol Pharm; 2009; 66(2):115-22. PubMed ID: 19719043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.